|
|
|
| Clinical effect of Qiyang Capsules on impotence in diabetes mellitus with kidney deficiency and blood stasis type |
| DING Qian1 ZHAO Feng2 LIU Qian1 ZHANG Qian2 YANG Xiaoli1 XU Yangtao3 |
1.Department of Traditional Chinese Medicine, the Second Central Hospital of Baoding, Hebei Province, Zhuozhou 072750, China;
2.Department of Rehabilitation, the Second Central Hospital of Baoding, Hebei Province, Zhuozhou 072750, China;
3.Department of Urology, the Second Central Hospital of Baoding, Hebei Province, Zhuozhou 072750, China
|
|
|
|
Abstract Objective To study the clinical effect of Qiyang Capsules on impotence in diabetes mellitus with kidney deficiency and blood stasis type. Methods A total of 160 patients with kidney deficiency and blood stasis type diabetes mellitus impotence treated in the Second Central Hospital of Baoding, Hebei Province from March 2017 to June 2019 were selected and divided into control group and observation group by coin toss method. The control group (71 cases) received routine hypoglycemic treatment and low-dose phosphodiesterase type 5 inhibitor, and the observation group (89 cases) were treated with Qiyang Capsules, for one month. The clinical efficacy, international index of erectile function-5 (IIEF-5) score, modified sexual life quality questionnaire-quality of life (mSLQQ-QoL) score, erectile hardness (EHS) grading , sex hormone levels (testosterone [T], testosterone estradiol [E2]) before and after treatment and adverse reactions of the two groups were compared. Results The clinical efficacy of the observation group was better than that of the control group, and the difference was statistically significant (P＜0.05). After treatment, IIEF-5 and mSLQQ-QoL scores in two groups were higher than before treatment, and those in the observation group were higher than those in the control group, the differences were statistically significant (P＜0.05). After treatment, the EHS grading of the two groups was better than that before treatment, and that of the observation group was better than that of the control group, the differences were statistically significant (P＜0.05). After treatment, T level in the two groups was higher than before treatment, and that in the observation group was higher than that in the control group, E2 level in the two groups was lower than before treatment, and that in the observation group was lower than that in the control group, the differences were statistically significant (P＜0.05). There was no significant difference in the total incidence of adverse reactions between the two groups (P＞0.05). Conclusion Qiyang Capsules can effectively improve erectile function and hardness, improve sexual life quality, and regulate sex hormone level in treatment of kidney deficiency and blood stasis type diabetes mellitus impotence, without significant adverse reactions.
|
|
|
|
|
|
[1] 胡海林，何清湖.谭新华治疗勃起功能障碍临床药对浅析[J].中华中医药杂志，2022，37（3）：1445-1447.
[2] 周鑫，杨婧瑜，史锐，等.基于数据挖掘技术探讨针灸治疗阳痿的选穴规律[J].中国针灸，2022，42（2）：215-220.
[3] 曾建峰，黄智峰，庄亮，等.丹阳汤对糖尿病性勃起功能障碍患者内皮细胞功能的影响[J].重庆医学，2022， 51（S01）：102-103.
[4] 贾晓岳，张育军，段玉红，等.少腹逐瘀汤联合西地那非治疗气滞血瘀型2型糖尿病性勃起功能障碍疗效观察[J].现代中西医结合杂志，2021，30（9）：931-935.
[5] 梁媛，马桂琴，刘红，等.5-磷酸二酯酶抑制剂他达拉非治疗对伴有感音神经性聋的性功能障碍患者听功能的影响[J].实用医学杂志，2020，36（17）：2420-2423.
[6] 王启新，卢文吉，孟慧，等.男性勃起功能障碍机制及中医药防治进展[J].中国中医基础医学杂志，2020，26（10）：1578-1581.
[7] 中华医学会糖尿病学分会.中国2型糖尿病防治指南（2017年版）[J].中国实用内科杂志，2018，38（4）：292-344.
[8] 彭丹涛，朱瑞，许贤豪.《精神障碍诊断与统计手册》-5神经认知障碍诊断标准（草案）[J].中华老年医学杂志，2011， 30（1）：7-12.
[9] 王琦.对《中药新药治疗阳痿的临床研究指导原则》有关阳痿诊断及疗效评定标准的商讨[J].中国性科学，1997， 6（4）：34-35.
[10] 吴以岭，魏聪，贾振华，等.从络病学说探讨糖尿病肾病的病机[J].中国中医基础医学杂志，2007，13（9）：659- 660.
[11] 中华中医药学会糖尿病分会.糖尿病勃起功能障碍中医诊疗标准[J].世界中西医结合杂志，2011，6（2）：180- 184.
[12] 赵峰，张红茹，丁乾，等.启阳胶囊联合小剂量5-磷酸二酯酶抑制剂治疗2型糖尿病性勃起功能障碍[J].医学研究与教育，2020，37（3）：28-31.
[13] 刘凤霞，阿卜杜热伊木江·如则，刘文娟，等.勃起功能障碍患者肝功能变化及其与IIEF-5、MSF-4评分关系分析[J].中国现代医学杂志，2020，30（17）：47-51.
[14] 戴继灿.改良的性生活质量调查表介绍[J].中国男科学杂志，2005，19（6）：71-72.
[15] 张向军，陈鸿杰，王军，等.微能量体外冲击波治疗男性勃起功能障碍的疗效观察[J].国际泌尿系统杂志，2020， 40（3）：513-515.
[16] 肖毅，陈万红，李求实，等.干针治疗2型糖尿病植物神经病变相关勃起功能障碍的临床疗效[J].西部医学，2022， 34（2）：280-283，288.
[17] 杨阿民，孟繁超，代恒恒，等.糖尿病性勃起功能障碍从络病论治经验[J].北京中医药，2021，40（8）：856-858.
[18] 杨小刚，李荣欣，丁永强，等.5型磷酸二酯酶抑制剂对精液质量影响的研究进展[J].中国性科学，2020，29（1）：13-17.
[19] 刘利杰，陈鑫，黄华伟，等.低能量体外冲击波治疗磷酸二酯酶-5抑制剂无反应性勃起功能障碍疗效研究[J].中国男科学杂志，2021，35（2）：19-23.
[20] 王浩，张继伟，高庆和，等.基于“五脏之伤，穷必及肾”对附子治疗阳痿的作用探讨[J].环球中医药，2021，14（9）：1646-1649.
[21] 张辉，刘鸿，王辉，等.崔学教教授治疗2型糖尿病型阳痿的方药规律研究[J].中国性科学，2021，30（2）：7-10.
[22] 薛珊珊，李海松，李霄，等.糖尿病性勃起功能障碍中医证治探讨[J].北京中医药，2021，40（8）：863-865.
[23] 李宪锐，王景尚，商建伟，等.填精通络汤联合他达拉非治疗肾虚血瘀型2型糖尿病勃起功能障碍的疗效观察[J].中国性科学，2022，31（6）：126-129.
[24] 杨治安，马建安，余勤.阻塞性睡眠呼吸暂停低通气综合征并发勃起功能障碍的发病机制及治疗进展[J].中国性科学，2022，31（4）：6-10.
[25] 曹龙滨，郭帅.补肾生精汤联合西药治疗勃起功能障碍的疗效及对血清性激素和性功能的影响[J].中国性科学，2022，31（11）：131-1340.
[26] 徐泽坤，徐姜南，盖年鑫，等.结合倾向性评分探究血清叶酸、维生素B12及同型半胱氨酸与勃起功能障碍的关系[J].中国男科学杂志，2022，36（1）：48-53. |
|
|
|
